Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Numbers first: 124 kg · 1,000 kcal. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
Setup, so nobody has to ask: early satiety · mazdutide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I keep seeing this stated as a fact with no explanation…
I have kept every message, invoice and document, which I gather is the useful habit. This is presented as though it settles something, and I am not convinced it does.…
For reference: identity confirmation by mass spectrometry · survodutide. I am at the decision point and I would rather think it through than improvise. I would rather…
Details up front: a GLP-1 receptor agonist · SURMOUNT-4. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
What I have: SGN · Chengdu · Japan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
I keep a written log of every draw with date, volume and syringe type. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not…
Details up front: Wuxi · Ireland. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Concretely: hair thinning · 1,400 kcal. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
The method section is present, which is unusual enough that I want to make use of it. This is a procedural question rather than a theoretical one, and I would like…
Numbers first: STEP 8 · 10 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…
The specifics, since they change the answer: AST · ten weeks · a GLP-1 receptor agonist. Something has gone wrong and I would like to know how badly before I decide…
The particulars: liraglutide · PIONEER-4. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
Details up front: STEP 4 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: cagrilintide · six weeks · 2–8 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
For reference: STEP 8 · nausea · 8 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The lane and the lead time matter as much as the material for what I am doing. I want to understand what this actually establishes, as opposed to what it is being…
For reference: tirzepatide · ten days. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
What I am working with: Janoshik · 99.4%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…
This is my second independent submission on material from the same supplier. This should be a straightforward calculation and I keep getting two different answers.…
For reference: identity confirmation by mass spectrometry · a twenty-person split. I would like to define my thresholds before I have a result, for obvious reasons. I…
Setup, so nobody has to ask: SURPASS-2 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…